The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT.
James B. Yu
No relevant relationships to disclose
Pamela R. Soulos
No relevant relationships to disclose
Laura D. Cramer
No relevant relationships to disclose
Kenneth B Roberts
No relevant relationships to disclose
Jeph Herrin
No relevant relationships to disclose
Arnold L. Potosky
No relevant relationships to disclose
Cary P. Gross
No relevant relationships to disclose